Coronavirus drug trials are underway – a virologist explains what the treatment options may be.
Alberta Premier Jason Kenney updates media on measures taken to help with COVID-19, in Edmonton on Friday, Mar. 20, 2020.
(THE CANADIAN PRESS/Jason Franson)
Alberta Premier Jason Kenney said he would not wait for Health Canada approval for coronavirus treatments and vaccines.
Development of vaccines typically takes several months and can be slowed by manufacturing requirements.
PHILIPPE DESMAZES/AFP via Getty Images
In the search for a rapid COVID-19 vaccine, researchers are modifying a method using the chemical riboflavin now used to prevent disease transmission during blood transfusions.
Is this for wheel?
Starting to feel a little more optimistic? Look away now.
Wouldn’t it be nice if getting a vaccine was a simple as putting on a Band-Aid?
University of Pittsburgh researchers are developing a vaccine patch for COVID-19 that is as easy to apply as a Band-Aid.
More clinical trials in African countries can help ensure that any vaccines or treatments developed cater to the continent’s genetic diversity.
CELLOU BINANI/AFP via Getty Images
More countries on the African continent must urgently get involved in clinical trials so that the data collected will accurately represent the continent at a genetic level.
Why do scientists care about mutations on the coronavirus?
Alexandr Gnezdilov Light Painting
The SARS-CoV-2 virus that causes COVID-19 is constantly mutating. What do these mutations reveal about this virus's evolution? And will this knowledge help us to develop a long-lasting vaccine?
One of Nairobi’s low-income areas.
Because low-income settlements are unplanned, crowded and without sanitation, there are many viral infections that cause health problems.
SARS-CoV-2 virus particles (pink dots) on a dying cell.
National Institute of Allergy and Infectious Diseases, NIH
The new coronavirus, SARS-CoV-2, spreads faster than the H1N1 influenza virus and is much deadlier. SARS-CoV-2 is particularly skilled at keeping cells from calling out for help.
If only COVID-19 testing was as simple as a pregnancy test.
There are now dozens of test for COVID-19 with hundreds more awaiting the FDA's authorization. So which test is best? Does anyone know?
Here's what protection from coronavirus looks like.
This scanning electron microscope image shows SARS-CoV-2 (round blue objects) emerging from the surface of cells cultured in the lab.
Traditional vaccines can take years to create. Rather than immunizing people with viral proteins, the new approach gives the molecular instructions that allows the body to make its own vaccine.
Scientific research on the novel coronavirus has progressed at unprecedented speed.
Mongkolchon Akesin / Shutterstock
While there is no cure for COVID-19, dozens of clinical trials are underway to test retroviral medicines and potential vaccines targeting the novel coronavirus.
There are many ways to make a vaccine. In a time of crisis, the more paths towards success the better.
Adriana Duduleanu / EyeEm via Getty Images
Under pressure to develop a coronavirus vaccine, researchers have turned to protein synthesis, genetics and hybrid viruses. It is likely a mix of these approaches will be used to fight the coronavirus.
Michelle Grattan interviews immunologist and Nobel Laureate Peter Doherty about controlling the coronavirus pandemic, and the prospects of developing a vaccine.
f a o.
Initiatives to develop a vaccine for COVID-19 are under way. But how far away are they?
We urgently need a vaccine for COVID-19 but exposing humans to a vaccine candidate that hasn't undergone the usual safety assessments is risky.
Getting vaccinated against the flu, washing your hands and social distancing are three ways you can help reduce the impact of both the flu and coronavirus.
Without a coronavirus vaccine, a herd immunity strategy would simply lead to thousands of unnecessary deaths.
Films that dissolve rapidly when placed under the tongue or high in the cheek will make vaccines cheaper and more reliable.
Stephen C. Schafer
Inspired by amber and hard candy, researchers figured out a new, needle-free, shelf-stable way to preserve vaccines, making them easier to ship and administer around the world.